VENLAFAXINE HYDROCHLORIDE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
62332-792 -
Package NDC
62332-792-30 -
Package NDC
62332-792-31 -
Package NDC
62332-792-71 -
Package NDC
62332-792-90 -
Package NDC
62332-792-91 -
Application number
ANDA217767 -
SPL ID
66ab68e0-e9f1-4576-8a95-6bbe3682fd9b -
SPL set ID
5c943206-6df8-4fc5-ab1d-d34b9715182c -
UNII
7D7RX5A8MO -
RxCUI
313581 -
RxCUI
313583 -
RxCUI
313585
What the source publishes
- Labeler
- Alembic Pharmaceuticals Inc.
- Active ingredients
- VENLAFAXINE HYDROCHLORIDE
- Form
- CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "VENLAFAXINE HYDROCHLORIDE",
"splId": "66ab68e0-e9f1-4576-8a95-6bbe3682fd9b",
"labels": [
{
"setId": "5c943206-6df8-4fc5-ab1d-d34b9715182c",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c943206-6df8-4fc5-ab1d-d34b9715182c",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5c943206-6df8-4fc5-ab1d-d34b9715182c"
}
],
"routes": [
"ORAL"
],
"labeler": "Alembic Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-792-30)",
"package_ndc": "62332-792-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20240610"
},
{
"sample": false,
"description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-792-31)",
"package_ndc": "62332-792-31",
"identifierStatus": "well-formed",
"marketing_start_date": "20240610"
},
{
"sample": false,
"description": "500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-792-71)",
"package_ndc": "62332-792-71",
"identifierStatus": "well-formed",
"marketing_start_date": "20240610"
},
{
"sample": false,
"description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-792-90)",
"package_ndc": "62332-792-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20240610"
},
{
"sample": false,
"description": "1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-792-91)",
"package_ndc": "62332-792-91",
"identifierStatus": "well-formed",
"marketing_start_date": "20240610"
}
],
"productId": "62332-792_66ab68e0-e9f1-4576-8a95-6bbe3682fd9b",
"useDomain": "unknown",
"dosageForm": "CAPSULE, EXTENDED RELEASE",
"productNdc": "62332-792",
"deaSchedule": null,
"genericName": "VENLAFAXINE HYDROCHLORIDE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "VENLAFAXINE HYDROCHLORIDE",
"strength": "37.5 mg/1"
}
],
"applicationNumber": "ANDA217767",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240610",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"7D7RX5A8MO"
],
"rxcui": [
"313581",
"313583",
"313585"
],
"spl_set_id": [
"5c943206-6df8-4fc5-ab1d-d34b9715182c"
],
"manufacturer_name": [
"Alembic Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:62332-792_66ab68e0-e9f1-4576-8a95-6bbe3682fd9b"